NINGBO INNO PHARMCHEM CO.,LTD. is proud to highlight a critical component in the pharmaceutical landscape: N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine. This complex organic molecule, identified by CAS number 231278-20-9, serves as an indispensable intermediate in the synthesis of Lapatinib, a vital drug used in the treatment of certain types of cancer, particularly breast cancer. The development of targeted therapies like Lapatinib relies heavily on the availability of high-purity chemical intermediates, and N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine stands out as a prime example of such a crucial building block.

The journey from raw chemical to a life-saving medication is intricate, demanding precision at every step. N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine, with its specific quinazoline core and functional groups, provides the structural foundation required for Lapatinib's pharmacological activity. Its role as a Lapatinib intermediate is paramount; without it, the efficient and large-scale production of this targeted therapy would be significantly hindered. Researchers and manufacturers often search for 'buy N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine' to ensure a reliable supply for their R&D and production needs.

The significance of this compound extends beyond its direct application in Lapatinib synthesis. It represents a class of advanced pharmaceutical intermediates that enable the creation of sophisticated molecular structures, which are the cornerstone of modern medicine. The N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine intermediate is not merely a chemical reagent; it is an enabler of scientific progress in the fight against diseases. The demand for high-purity versions, often sought as 'CAS 231278-20-9 pharmaceutical grade', underscores the stringent quality requirements in the pharmaceutical industry. NINGBO INNO PHARMCHEM CO.,LTD. is committed to meeting these demands by providing intermediates that adhere to the highest standards, facilitating the development of effective treatments.

Furthermore, the chemical structure of N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine, a quinazoline derivative, is of great interest in medicinal chemistry. Quinazoline scaffolds are known for their diverse biological activities, and this specific derivative is a testament to the power of targeted molecular design. The ongoing research into similar compounds and their applications in various therapeutic areas highlights the enduring importance of these complex intermediates. For those involved in organic synthesis and pharmaceutical development, understanding the properties and applications of such compounds is key to innovation.